Monthly Archives: October 2012

A Japanese and a British scientist were awarded the 2012 Nobel Prize in physiology or medicine Monday for their groundbreaking work in turning adult cells into immature ones that might be tweaked further to treat a wide spectrum of diseases. Such research is being aggressively pursued at scientific institutions across San Diego County.

Shinya Yamanaka of Japan and John Gurdon of Great Britain showed that it is possible to alter adult cells to the point where they are very similar to human embryonic stem cells. But the process does not involved the destruction of embryos.

In essence, scientists can now take cells from, say, a person's skin and turn back the clock, making the cell essentially act as though it were new.

The Nobel Assembly at the Karolinska Institute issued a statement today saying, "These groundbreaking discoveries have completely changed our view of the development and cellular specialisation. We now understand that the mature cell does not have to be confined forever to its specialised state. Textbooks have been rewritten and new research fields have been established. By reprogramming human cells, scientists have created new opportunities to study diseases and develop methods for diagnosis and therapy.

"The discoveries of Gurdon and Yamanaka have shown that specialised cells can turn back the developmental clock under certain circumstances. Although their genome undergoes modifications during development, these modifications are not irreversible. We have obtained a new view of the development of cells and organisms.

"Research during recent years has shown that iPS cells can give rise to all the different cell types of the body. These discoveries have also provided new tools for scientists around the world and led to remarkable progress in many areas of medicine. iPS cells can also be prepared from human cells.

"For instance, skin cells can be obtained from patients with various diseases, reprogrammed, and examined in the laboratory to determine how they differ from cells of healthy individuals. Such cells constitute invaluable tools for understanding disease mechanisms and so provide new opportunities to develop medical therapies."

Gurdon -- who was working in his lab today when he learned that he'd won a Nobel -- made the initial breakthrough about 50 years ago, and Yamanaka built on that work, accelerating the process through genetic engineering.

The Sanford-Burnham Medical Research Institute was created in La Jolla, in part, to probe exactly this area of research.

Will La Jolla scientists win this year's Nobel Prizes?

Read more:
Nobel Prize awarded for work on stem cells

NEW YORK -- Two scientists from different generations won the Nobel Prize in medicine Monday for the groundbreaking discovery that cells in the body can be reprogrammed into completely different kinds -- work that reflects the mechanism behind cloning and offers an alternative to using embryonic stem cells.

The work of British researcher John Gurdon and Japanese scientist Shinya Yamanaka -- who was born the year Gurdon made his discovery -- holds hope for treating diseases such as Parkinson's and diabetes by growing customized tissue for transplant.

And it has spurred a new generation of laboratory studies into other illnesses, including schizophrenia, which may lead to new treatments.

Basically, Gurdon, 79, and Yamanaka, 50, showed how to make the equivalent of embryonic stem cells without the ethical questions those versatile cells pose.

Once created, these "blank slate" cells can be nudged toward developing into other cell types. Skin cells can ultimately be transformed into brain cells, for example.

Just last week, scientists reported turning skin cells from mice into eggs that produced baby mice, a possible step toward new fertility treatments.

Gurdon and Yamanaka performed "courageous experiments" that challenged scientific opinion, said Doug Melton, co-director of the Harvard Stem Cell Institute.

"Their work shows ... that while cells might be specialized to do one thing, they have the potential to do something else," Melton said. It "really lays the groundwork for all the excitement about stem cell biology."

In announcing the $1.2-million award, the Nobel committee at the Karolinska Institute in Stockholm, Sweden, said the work has "revolutionized our understanding of how cells and organisms develop."

Gurdon showed in 1962 that DNA from specialized cells of tadpoles, such as skin or intestinal cells, could be used to clone more tadpoles. In 1997, the same process led to the cloning of Dolly the sheep, showing it also would work in mammals.

Continued here:
2 scientists win Nobel Prize for discoveries that offer alternative to embryonic stem cells

By Nonie Arora

Medicine is about more than difficult diagnoses and cutting-edge research. Research and treatments often raise tricky moral questions.

Jeremy Sugarman Credit: Berman Institute for Bioethics

Dr. Jeremy Sugarman, the founding director for the Trent Center for Bioethics, returned to campus last week to give a talk on the ethics of stem cell research and treatment for the Humanities in Medicine Lecture Series.

Stem cells are a hot topic that have captured the imagination of people around the world, he said.

Is it better to use leftover embryos from IVF or to create them for research? Sugarman asked. He said there is little consensus on this issue, and the question remains whether there is a moral distinction between discarded embryos or those created for research purposes. There is also the thorny issue of whether it is morally acceptable to destroy embryos to create human embryonic stem cells, said Sugarman, who is now at the Berman Institute for Bioethics at Johns Hopkins University.

Amidst the controversy surrounding the moral status of embryos, there has also beenscientific controversy within the stem cell field. Sugarman spoke of Hwang Woo-Suk, who claimed to have cloned human embryos and extracted their stem cells. However, his data was fabricated, Sugarman said. Sugarman elicited laughs from the packed audience when he joked about Woo-Suks former title Supreme Scientist of Korea, an honor that was later revoked. The laughter was tempered by the understanding of how unethical it is to fake any research, but especially on this scale. Still, Sugarman says Woo-Suks example serves to show the effectiveness of peer review in realizing false claims.

Human Embryonic Stem Cells. Source: "Follow the Money The Politics of Embryonic Stem Cell Research." Russo E, PLoS Biology Vol. 3/7/2005, e234 http://dx.doi.org/10.1371/journal.pbio.0030234

Another issue many people are concerned about are chimeras organisms that have parts from two different genetic lines. Already, bone marrow transplants create human-to-human chimeras, Sugarman explained. Some people have qualms about combining materials from human and non-human animals.

Other countries differ from the U.S. in policies on what can be done with human embryonic stem cells. For instance, in Germany it is a criminal offense to destroy an embryo to create a human embryonic stem cell line. It is also illegal for a German citizen to do such work abroad, Sugarman said. He brought up this point to illustrate why local oversight within academic institutions is necessary to not only make sure that research is ethically and scientifically sound but to also be certain that researchers are being protected.

Go here to see the original:
Stem Cells' Tricky Questions

08-10-2012 20:30 England's Sir John Gurdon and Dr. Shinya Yamanaka from Japan share the 2012 Nobel Prize in medicine for work on stem cells, revealing that mature cells can be reverted into primitive cells. Ray Suarez talks to Harvard Stem Cell Institute's Dr. David Scadden, who explains the implications and applications for stem cell medicine.

View post:
Stem Cell Scientists Win Nobel Prize in Medicine - Video